265 POSTER Recombinant human Interleukin-21 (rIL-21), a new cytokine for immunotherapy: results of two phase 1 studies in patients with metastatic melanoma (MM) or renal cell carcinoma (RCC)
- 30 November 2006
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 4 (12) , 84-85
- https://doi.org/10.1016/s1359-6349(06)70270-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: